Furthermore, conjugates targeting programmed cell death-ligand 1 (PD-L1-IR700) induced significant therapeutic responses in subcutaneous models of lung papillary adenocarcinomas overexpressing PD-L1 antigens in athymic nude mice (Nagaya et al., 2017c). This evidence concerns the gene CD274 and papillary lung adenocarcinoma.